Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Brain Res ; 1676: 38-45, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-28917524

ABSTRACT

Tremor dominant Kyoto (Trdk) is an autosomal dominant mutation that appeared in F344/NSlc rats mutagenized with N-ethyl-N-nitrosourea (ENU). In this study, we characterized and genetically analyzed F344-Trdk/+ heterozygous rats. The rats exhibited a tremor that was especially evident around weaning but persisted throughout life. The tremors of F344-Trdk/+ rats were attenuated by drugs effective against essential tremor (ET) but not drugs used to treat Parkinson's disease-related tremor, indicating that the pharmacological phenotype of F344-Trdk/+ rats was similar to human ET. Using positional candidate approach, we identified the Trdk mutation as a missense substitution (c. 866T>A, p. I289N) in Kcnn2, which encodes the SK2 subunit of the small-conductance Ca2+-activated K+ channel. In vitro electrophysiological studies revealed that the I289N mutation diminished SK2 channel activity. These findings demonstrate that F344-Trdk/+ rats represent a novel model of ET, and strongly suggest that Kcnn2 is the causative gene for the tremor phenotype in F344-Trdk/+ rats.


Subject(s)
Mutation, Missense , Rats, Inbred F344 , Rats, Mutant Strains , Small-Conductance Calcium-Activated Potassium Channels/genetics , Tremor/genetics , Animals , Anti-Dyskinesia Agents/pharmacology , Brain/metabolism , Brain/pathology , Chromosome Mapping , Disease Models, Animal , Essential Tremor/drug therapy , Essential Tremor/genetics , Essential Tremor/metabolism , Essential Tremor/pathology , HEK293 Cells , Humans , Immunohistochemistry , In Situ Hybridization , Patch-Clamp Techniques , Phenotype , Small-Conductance Calcium-Activated Potassium Channels/metabolism , Transfection , Tremor/drug therapy , Tremor/metabolism , Tremor/pathology
SELECTION OF CITATIONS
SEARCH DETAIL